Cargando…

Impact of Duration of Mitral Regurgitation on Outcomes in Asymptomatic Patients With Myxomatous Mitral Valve Undergoing Exercise Stress Echocardiography

BACKGROUND: Significant mitral regurgitation (MR) typically occurs as holosystolic (HS) or mid‐late systolic (MLS), with differences in volumetric impact on the left ventricle (LV). We sought to assess outcomes of degenerative MR patients undergoing exercise echocardiography, separated based on MR d...

Descripción completa

Detalles Bibliográficos
Autores principales: Naji, Peyman, Asfahan, Fadi, Barr, Tyler, Rodriguez, L. Leonardo, Grimm, Richard A., Agarwal, Shikhar, Thomas, James D., Gillinov, A. Marc, Mihaljevic, Tomislav, Griffin, Brian P., Desai, Milind Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345867/
https://www.ncbi.nlm.nih.gov/pubmed/25672368
http://dx.doi.org/10.1161/JAHA.114.001348
_version_ 1782359642302578688
author Naji, Peyman
Asfahan, Fadi
Barr, Tyler
Rodriguez, L. Leonardo
Grimm, Richard A.
Agarwal, Shikhar
Thomas, James D.
Gillinov, A. Marc
Mihaljevic, Tomislav
Griffin, Brian P.
Desai, Milind Y.
author_facet Naji, Peyman
Asfahan, Fadi
Barr, Tyler
Rodriguez, L. Leonardo
Grimm, Richard A.
Agarwal, Shikhar
Thomas, James D.
Gillinov, A. Marc
Mihaljevic, Tomislav
Griffin, Brian P.
Desai, Milind Y.
author_sort Naji, Peyman
collection PubMed
description BACKGROUND: Significant mitral regurgitation (MR) typically occurs as holosystolic (HS) or mid‐late systolic (MLS), with differences in volumetric impact on the left ventricle (LV). We sought to assess outcomes of degenerative MR patients undergoing exercise echocardiography, separated based on MR duration (MLS versus HS). METHODS AND RESULTS: We included 609 consecutive patients with ≥III+myxomatous MR undergoing exercise echocardiography: HS (n=487) and MLS (n=122). MLS MR was defined as delayed appearance of MR signal during mid‐late systole on continuous‐wave Doppler while HS MR occurred throughout systole. Composite events of death and congestive heart failure were recorded. Compared to MLS MR, HS MR patients were older (60±14 versus 53±14 years), more were males (72% versus 53%), and had greater prevalence of atrial fibrillation (16% versus 7%; all P<0.01). HS MR patients had higher right ventricular systolic pressure (RVSP) at rest (33±11 versus 27±9 mm Hg), more flail leaflets (36% versus 6%), and a lower number of metabolic equivalents (METs) achieved (9.5±3 versus 10.5±3), compared to the MLS MR group (all P<0.05). There were 54 events during 7.1±3 years of follow‐up. On step‐wise multivariable analysis, HS versus MLS MR (HR 4.99 [1.21 to 20.14]), higher LV ejection fraction (hazard ratio [HR], 0.94 [0.89 to 0.98]), atrial fibrillation (HR, 2.59 [1.33 to 5.11]), higher RVSP (HR, 1.05 [1.03 to 1.09]), and higher percentage of age‐ and gender‐predicted METs (HR, 0.98 [0.97 to 0.99]) were independently associated with adverse outcomes (all P<0.05). CONCLUSION: In patients with ≥III+myxomatous MR undergoing exercise echocardiography, holosystolic MR is associated with adverse outcomes, independent of other predictors.
format Online
Article
Text
id pubmed-4345867
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-43458672015-03-10 Impact of Duration of Mitral Regurgitation on Outcomes in Asymptomatic Patients With Myxomatous Mitral Valve Undergoing Exercise Stress Echocardiography Naji, Peyman Asfahan, Fadi Barr, Tyler Rodriguez, L. Leonardo Grimm, Richard A. Agarwal, Shikhar Thomas, James D. Gillinov, A. Marc Mihaljevic, Tomislav Griffin, Brian P. Desai, Milind Y. J Am Heart Assoc Original Research BACKGROUND: Significant mitral regurgitation (MR) typically occurs as holosystolic (HS) or mid‐late systolic (MLS), with differences in volumetric impact on the left ventricle (LV). We sought to assess outcomes of degenerative MR patients undergoing exercise echocardiography, separated based on MR duration (MLS versus HS). METHODS AND RESULTS: We included 609 consecutive patients with ≥III+myxomatous MR undergoing exercise echocardiography: HS (n=487) and MLS (n=122). MLS MR was defined as delayed appearance of MR signal during mid‐late systole on continuous‐wave Doppler while HS MR occurred throughout systole. Composite events of death and congestive heart failure were recorded. Compared to MLS MR, HS MR patients were older (60±14 versus 53±14 years), more were males (72% versus 53%), and had greater prevalence of atrial fibrillation (16% versus 7%; all P<0.01). HS MR patients had higher right ventricular systolic pressure (RVSP) at rest (33±11 versus 27±9 mm Hg), more flail leaflets (36% versus 6%), and a lower number of metabolic equivalents (METs) achieved (9.5±3 versus 10.5±3), compared to the MLS MR group (all P<0.05). There were 54 events during 7.1±3 years of follow‐up. On step‐wise multivariable analysis, HS versus MLS MR (HR 4.99 [1.21 to 20.14]), higher LV ejection fraction (hazard ratio [HR], 0.94 [0.89 to 0.98]), atrial fibrillation (HR, 2.59 [1.33 to 5.11]), higher RVSP (HR, 1.05 [1.03 to 1.09]), and higher percentage of age‐ and gender‐predicted METs (HR, 0.98 [0.97 to 0.99]) were independently associated with adverse outcomes (all P<0.05). CONCLUSION: In patients with ≥III+myxomatous MR undergoing exercise echocardiography, holosystolic MR is associated with adverse outcomes, independent of other predictors. Blackwell Publishing Ltd 2015-02-12 /pmc/articles/PMC4345867/ /pubmed/25672368 http://dx.doi.org/10.1161/JAHA.114.001348 Text en © 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Naji, Peyman
Asfahan, Fadi
Barr, Tyler
Rodriguez, L. Leonardo
Grimm, Richard A.
Agarwal, Shikhar
Thomas, James D.
Gillinov, A. Marc
Mihaljevic, Tomislav
Griffin, Brian P.
Desai, Milind Y.
Impact of Duration of Mitral Regurgitation on Outcomes in Asymptomatic Patients With Myxomatous Mitral Valve Undergoing Exercise Stress Echocardiography
title Impact of Duration of Mitral Regurgitation on Outcomes in Asymptomatic Patients With Myxomatous Mitral Valve Undergoing Exercise Stress Echocardiography
title_full Impact of Duration of Mitral Regurgitation on Outcomes in Asymptomatic Patients With Myxomatous Mitral Valve Undergoing Exercise Stress Echocardiography
title_fullStr Impact of Duration of Mitral Regurgitation on Outcomes in Asymptomatic Patients With Myxomatous Mitral Valve Undergoing Exercise Stress Echocardiography
title_full_unstemmed Impact of Duration of Mitral Regurgitation on Outcomes in Asymptomatic Patients With Myxomatous Mitral Valve Undergoing Exercise Stress Echocardiography
title_short Impact of Duration of Mitral Regurgitation on Outcomes in Asymptomatic Patients With Myxomatous Mitral Valve Undergoing Exercise Stress Echocardiography
title_sort impact of duration of mitral regurgitation on outcomes in asymptomatic patients with myxomatous mitral valve undergoing exercise stress echocardiography
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345867/
https://www.ncbi.nlm.nih.gov/pubmed/25672368
http://dx.doi.org/10.1161/JAHA.114.001348
work_keys_str_mv AT najipeyman impactofdurationofmitralregurgitationonoutcomesinasymptomaticpatientswithmyxomatousmitralvalveundergoingexercisestressechocardiography
AT asfahanfadi impactofdurationofmitralregurgitationonoutcomesinasymptomaticpatientswithmyxomatousmitralvalveundergoingexercisestressechocardiography
AT barrtyler impactofdurationofmitralregurgitationonoutcomesinasymptomaticpatientswithmyxomatousmitralvalveundergoingexercisestressechocardiography
AT rodriguezlleonardo impactofdurationofmitralregurgitationonoutcomesinasymptomaticpatientswithmyxomatousmitralvalveundergoingexercisestressechocardiography
AT grimmricharda impactofdurationofmitralregurgitationonoutcomesinasymptomaticpatientswithmyxomatousmitralvalveundergoingexercisestressechocardiography
AT agarwalshikhar impactofdurationofmitralregurgitationonoutcomesinasymptomaticpatientswithmyxomatousmitralvalveundergoingexercisestressechocardiography
AT thomasjamesd impactofdurationofmitralregurgitationonoutcomesinasymptomaticpatientswithmyxomatousmitralvalveundergoingexercisestressechocardiography
AT gillinovamarc impactofdurationofmitralregurgitationonoutcomesinasymptomaticpatientswithmyxomatousmitralvalveundergoingexercisestressechocardiography
AT mihaljevictomislav impactofdurationofmitralregurgitationonoutcomesinasymptomaticpatientswithmyxomatousmitralvalveundergoingexercisestressechocardiography
AT griffinbrianp impactofdurationofmitralregurgitationonoutcomesinasymptomaticpatientswithmyxomatousmitralvalveundergoingexercisestressechocardiography
AT desaimilindy impactofdurationofmitralregurgitationonoutcomesinasymptomaticpatientswithmyxomatousmitralvalveundergoingexercisestressechocardiography